E
Erica Vetrano
Researcher at Seconda Università degli Studi di Napoli
Publications - 29
Citations - 359
Erica Vetrano is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 13 publications receiving 35 citations.
Papers
More filters
Journal ArticleDOI
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Teresa Salvatore,Pia Clara Pafundi,Raffaele Galiero,Luca Rinaldi,Alfredo Caturano,Erica Vetrano,Concetta Aprea,Gaetana Albanese,Anna Di Martino,Carmen Ricozzi,Simona Imbriani,Ferdinando Carlo Sasso +11 more
TL;DR: In this paper, a review of metformin's beneficial effects on endothelium-dependent vascular response in type 2 diabetes patients is presented, which could preempt development of atherosclerosis.
Journal ArticleDOI
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Teresa Salvatore,Pia Clara Pafundi,Raffaele Galiero,Gaetana Albanese,Anna Di Martino,Alfredo Caturano,Erica Vetrano,Luca Rinaldi,Ferdinando Carlo Sasso +8 more
TL;DR: In this paper, the major pathophysiological changes and the underlying mechanisms leading to myocardial remodeling and cardiac functional derangement in DM-CMP were outlined. But, the authors did not consider the effect of other risk factors such as metabolic abnormalities such as lipotoxicity and glucotoxicity.
Journal ArticleDOI
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.
Raffaele Galiero,Pia Clara Pafundi,Vittorio Simeon,Luca Rinaldi,Alessandro Perrella,Erica Vetrano,Alfredo Caturano,Maria Rosaria Alfano,Domenico Beccia,Riccardo Nevola,Raffaele Marfella,Celestino Sardu,Carmine Coppola,Ferdinando Scarano,Paolo Maggi,Pellegrino De Lucia Sposito,Laura Vocciante,Carolina Rescigno,Costanza Sbreglia,Fiorentino Fraganza,Roberto Parrella,Annamaria Romano,Giosuele Calabria,Benedetto Polverino,Antonio Pagano,Carolina Bologna,Maria Amitrano,Vincenzo Esposito,Nicola Coppola,Nicola Maturo,Luigi Elio Adinolfi,Paolo Chiodini,Ferdinando Carlo Sasso +32 more
TL;DR: Mortality of patients hospitalized for COVID-19 appears strongly affected by both clinical conditions on admission and comorbidities, with a very poor outcome in subjects with a chronic liver disease, alongside with an increase of hepatic damage.
Journal ArticleDOI
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
Ferdinando Carlo Sasso,Pia Clara Pafundi,Alfredo Caturano,Raffaele Galiero,Erica Vetrano,Riccardo Nevola,Salvatore Petta,Anna Ludovica Fracanzani,Carmine Coppola,Vito Di Marco,Antonio Solano,Rosa Lombardi,Mauro Giordano,Antonio Craxì,Alessandro Perrella,Celestino Sardu,Raffaele Marfella,Teresa Salvatore,Luigi Elio Adinolfi,Luca Rinaldi +19 more
TL;DR: In this paper, a prospective multicenter study was conducted to assess how direct acting antivirus (DAAs) could affect major cardiovascular events (MACE) in a prediabetic HCV positive cohort.
Journal ArticleDOI
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease
Raffaele Galiero,Alfredo Caturano,Erica Vetrano,Arturo Cesaro,Luca Rinaldi,Teresa Salvatore,Raffaele Marfella,Celestino Sardu,Elisabetta Moscarella,Felice Gragnano,Paolo Calabrò,Ferdinando Carlo Sasso +11 more
TL;DR: In this paper, a review extensively discusses and comments current and developing NAFLD therapies and their possible impact on cardiovascular outcome and their potential impact on atherosclerotic plaque formation and progression.